Latest News & Features
Big Pharma
"The disadvantage of going for an Arrow declaration is that you have to put all your cards on the table," says Lorna Brazell of Osborne Clarke. 30 March 2017
Americas
Last year was a historic one for the US Federal Trade Commission, according to its “Annual Highlights” report, issued yesterday. 29 March 2017
Americas
The European Patent Office has revealed its intention to grant a patent covering the CRISPR gene-editing technology to the University of California, Berkeley, the University of Vienna, and inventor Emmanuelle Charpentier. 28 March 2017
Americas
The Patent Trial and Appeal Board has upheld a Research Corporation Technologies patent for anti-epileptic drug Vimpat in a case brought by Argentum Pharmaceuticals. 27 March 2017
Americas
A Los Angeles-based man has pleaded guilty to illegally importing active ingredients used in erectile dysfunction drugs with a value of up to $550,000. 27 March 2017
Americas
A new law on supplementary protection certificates will be implemented on April 1, with the application, prosecution and maintenance of SPCs taking centre stage. José Manuel González
of Clarke, Modet & Co reports. 27 March 2017
Americas
The US Court of Appeals for the Federal Circuit has backed a district court decision that a patent lawsuit against the University of Utah was not exceptional, thereby denying fees to the Max Planck Society for the Advancement of Science. 24 March 2017
Americas
Pfizer has sued Breckenridge Pharmaceutical, Pensa Pharma and Laboratorios del Dr Esteve for patent infringement of its drug Xeljanz. 24 March 2017
Americas
The US Chamber of Commerce has urged the Canadian government to address its ‘promise utility doctrine’, claiming that it “dramatically undermines legal certainty for medical innovators in Canada”. 23 March 2017
Americas
A Biogen patent covering the drug Tecfidera has been upheld by the Patent Trial and Appeal Board, after a challenge from Kyle Bass’s Coalition for Affordable Drugs. 23 March 2017